Insights On Trial Design
-
Streamlining Study Start-Up For Accelerated Drug Development
2/20/2024
What is the secret to safely expediting study start-ups? Explore our case study to find out how open dialogue, aligned expectations, and direct communication between Altasciences’ team leads and sponsor contributed to a clinical trial start-up of only 3.5 weeks.
-
Taking A Statistics-Driven Approach To Clinical Trial Planning
3/12/2025
Clinical trials are inherently complex, and even well-structured studies may struggle to achieve statistical significance due to challenges in study design, patient selection, and data variability.
-
Bladder Cancer Global Clinical Trial Landscape (2024)
11/12/2024
Bladder cancer is the ninth most common cancer in the world and thirteenth in mortality. This report provides a detailed overview of the clinical trial landscape for bladder cancer.
-
Five Predictions For Clinical Research In 2025
2/19/2025
In 2025, AI-powered adaptive protocols will redefine study design, shifting the industry from rigid, pre-planned models to flexible, real-world-optimized trials.
-
A Promising Rebound in Clinical Trials
10/23/2024
This report explores how clinical trials bounced back in 2023 from their decline a year earlier despite continued geopolitical, regulatory, and pricing pressures.
-
Pancreatic Cancer: Global Clinical Trial Landscape (2024)
9/17/2024
Explore the latest advancements in pancreatic cancer research with this comprehensive disease report, covering new treatments, clinical trials, and future innovations in care.
-
10 Ways To Set Up Your Sites For Recruitment Success
7/16/2024
Selecting the right trial sites is key to success. Choose sites with the right experience, patient population, diversity mix, and timelines. See these nine tips to boost recruitment and retention.
-
Achieving Person-Centricity In Clinical Trial Recruitment
4/14/2025
Clinical trial enrollment remains a major bottleneck in drug development, but consumer-centric innovations could present a solution to enhance every stage of clinical trial enrollment.
-
ICH E6(R3): 10 FAQ On What Changed And What It Means For Your Trials
9/18/2025
The ICH E6(R3) updated guidelines present 10 critical changes to make clinical trials more efficient, adaptable, and patient-centric, while upholding the standards of scientific and ethical integrity.
-
RTSM And Clinical Drug Dispensation
7/16/2024
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.